JP2012510477A5 - - Google Patents

Download PDF

Info

Publication number
JP2012510477A5
JP2012510477A5 JP2011538797A JP2011538797A JP2012510477A5 JP 2012510477 A5 JP2012510477 A5 JP 2012510477A5 JP 2011538797 A JP2011538797 A JP 2011538797A JP 2011538797 A JP2011538797 A JP 2011538797A JP 2012510477 A5 JP2012510477 A5 JP 2012510477A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
compound
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011538797A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012510477A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2009/001572 external-priority patent/WO2010063069A1/en
Publication of JP2012510477A publication Critical patent/JP2012510477A/ja
Publication of JP2012510477A5 publication Critical patent/JP2012510477A5/ja
Pending legal-status Critical Current

Links

JP2011538797A 2008-12-02 2009-12-02 放射性医用薬剤としての窒素含有大環状結合体 Pending JP2012510477A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008906239A AU2008906239A0 (en) 2008-12-02 Radiopharmaceuticals
AU2008906239 2008-12-02
PCT/AU2009/001572 WO2010063069A1 (en) 2008-12-02 2009-12-02 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015022109A Division JP5981580B2 (ja) 2008-12-02 2015-02-06 放射性医用薬剤としての窒素含有大環状結合体

Publications (2)

Publication Number Publication Date
JP2012510477A JP2012510477A (ja) 2012-05-10
JP2012510477A5 true JP2012510477A5 (enExample) 2013-01-24

Family

ID=42232814

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011538797A Pending JP2012510477A (ja) 2008-12-02 2009-12-02 放射性医用薬剤としての窒素含有大環状結合体
JP2015022109A Active JP5981580B2 (ja) 2008-12-02 2015-02-06 放射性医用薬剤としての窒素含有大環状結合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015022109A Active JP5981580B2 (ja) 2008-12-02 2015-02-06 放射性医用薬剤としての窒素含有大環状結合体

Country Status (9)

Country Link
US (7) US9701694B2 (enExample)
EP (2) EP2370447B1 (enExample)
JP (2) JP2012510477A (enExample)
CN (1) CN102300866B (enExample)
AU (1) AU2009322081C1 (enExample)
CA (1) CA2745495C (enExample)
DK (1) DK3098225T3 (enExample)
ES (1) ES2712881T3 (enExample)
WO (1) WO2010063069A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10717741B2 (en) 2011-07-07 2020-07-21 Australian Nuclear Science And Technology Organisation Cryptate compounds
ES2617335T3 (es) * 2011-12-06 2017-06-16 The University Of Melbourne Funcionalización de ligandos amino con estructura de jaula para agentes metalo-radiofarmacéuticos
US9457107B2 (en) 2011-12-06 2016-10-04 The University Of Melbourne Cage amine ligands for metallo-radiopharmaceuticals
US9422286B2 (en) 2014-01-27 2016-08-23 Washington University Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease
GB201417067D0 (en) 2014-09-26 2014-11-12 South African Nuclear Energy Radiopharmaceutical conjugate
CA3042737A1 (en) * 2016-11-04 2018-05-11 Clarity Pharmaceuticals Pty Ltd Formulations for radiotherapy and diagnostic imaging
CN110914274B (zh) * 2017-06-06 2022-08-26 透明医药有限公司 放射性药物、放射成像剂及其用途
EP3773553A4 (en) * 2018-04-11 2022-03-09 Clarity Pharmaceuticals Limited RADIOTHERAPY AND DIAGNOSTIC IMAGING FORMULATIONS AND KITS
CN111989324A (zh) * 2018-04-11 2020-11-24 墨尔本大学 靶向化合物及其生产方法
SG11202111350RA (en) * 2019-05-24 2021-11-29 Clarity Pharmaceuticals Ltd Formulations of psma imaging agents
JP2023500377A (ja) * 2019-11-08 2023-01-05 ザ・ユニバーシティ・オブ・クイーンズランド 放射性標識された標的化リガンド
WO2021150258A1 (en) * 2020-01-26 2021-07-29 Mainline Biosciences Llc Isotopically labelled selective cxcr4 binding peptide conjugate and methods for making and using the same
US20230165979A1 (en) * 2020-05-06 2023-06-01 Cornell University Copper-containing theragnostic compositions and methods of use
EP4196175A4 (en) * 2020-08-14 2025-07-30 Clarity Pharmaceuticals Ltd RADIOPHARMACEUTICAL COMPOUNDS, THEIR USES AND PROCESSES FOR THEIR PRODUCTION
EP4568712A1 (en) * 2022-08-11 2025-06-18 Clarity Pharmaceuticals Limited Dimeric radiopharmaceuticals, compositions thereof and uses thereof
CN116589508A (zh) * 2023-05-16 2023-08-15 洛阳师范学院 一种基于半夹心铑构筑单元的矩形分子大环化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001719A1 (en) 1977-10-26 1979-05-02 The Australian National University Metal complexes, their preparation and production of hydrogen peroxide therewith
CN1033030C (zh) * 1988-06-24 1996-10-16 唐化学原料公司 大环双官能螯合剂及其配合物和抗体共轭物的制备方法
US5245055A (en) * 1990-12-18 1993-09-14 E. R. Squibb & Sons, Inc. Process for preparing a cis oxabicyclo olefinic acid and ester from an oxabicyclo pyranol
JPH04244085A (ja) 1990-12-21 1992-09-01 Doujin Kagaku Kenkyusho:Kk 蛍光性化合物、錯体、試薬および該試薬を用いる特異的結合アッセイ
AU706642B2 (en) * 1994-04-22 1999-06-17 G.D. Searle & Co. Diagnostic image analysis with metal complexes
WO1995031202A1 (en) * 1994-05-17 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Cage compounds, processes for their preparation and their use as antiviral agents
AUPP803899A0 (en) * 1999-01-05 1999-01-28 Australian National University, The Cryptate compounds and methods for diagnosis and therapy.
US6107326A (en) * 1999-04-12 2000-08-22 Cytopharm, Inc. Porphycenes for treatment of microbial populations
GB0116815D0 (en) 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
EP1331012A1 (en) * 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Responsive paramagnetic MRI contrast agents
FI20031528A0 (fi) * 2003-10-17 2003-10-17 Ctt Cancer Targeting Tech Oy Terapeuttinen liposomikoostumus ja menetelmä sen valmistamiseksi
WO2008147481A1 (en) * 2007-02-09 2008-12-04 Northeastern University Precision-guided nanoparticle systems for drug delivery

Similar Documents

Publication Publication Date Title
JP4560210B2 (ja) 薬物複合体
JPH02501141A (ja) テトラ‐アザ大環状化合物およびその金属錯体
JP5981580B2 (ja) 放射性医用薬剤としての窒素含有大環状結合体
JP2020508985A5 (enExample)
JP2014503574A5 (enExample)
JP2008533191A5 (enExample)
US20200069698A1 (en) Texaphyrin-pt(iv) conjugates and compositions for use in overcoming platinum resistance
AU2019383466B2 (en) Therapeutic dendrimer
JP2020531591A (ja) 相乗的抗癌活性を有する中間体薬剤およびポリエチレングリコール共役相乗的抗癌薬、ならびにその製造方法およびその使用
JP2010511687A5 (enExample)
JP2016509586A5 (enExample)
CN104169291B (zh) 新化学实体钙锰福地吡和其他混合金属配合物、制备方法、组合物以及治疗方法
US20160220689A1 (en) Macromolecules of dendrimer-platinum conjugates
CN120731208A (zh) 新型喜树碱衍生物及其偶联物
DK2788354T3 (en) FUNCTIONALIZATION OF CAGE AMINIGANDS FOR METALLO-RADIOPHARMACEUTICAL AGENTS
CZ286404B6 (en) Platinum complex compounds, process of their preparation and pharmaceutical preparation containing thereof
JP2000509030A (ja) グリコペプチド化合物
JP2025540961A (ja) タンパク質の内在化のための組成物および方法
JP2015500246A5 (enExample)
US12616711B2 (en) Therapeutic dendrimer
AU2012278938A1 (en) Cryptate compounds
JP2005524622A5 (enExample)
JP2006520768A (ja) 金属イオンのキレート化剤として有用な窒素含有多環式誘導体およびそれらの用途
KR20250019081A (ko) 약물 링커 접합체의 제조 방법 및 이의 중간체
US20250066411A1 (en) Glycomimetic binders for l-sign